Bristol-Myers Squibb Company
NYSE: BMY
$49.41
+$0.39 (+0.8%)
Closing Price on September 20, 2024
BMY Articles
These are ten of the analyst calls we are focusing on this Wednesday morning in pre-market trading: Bristol-Myers (NYSE: BMY) cut to Neutral at Cowen. Marriott (NYSE: MAR) cut to Perform at...
Published:
Bristol-Myers Squibb (NYSE: BMY) has submitted an open shelf offering today for an undetermined amount. The offering includes a combination of debt securities, preferred stock, depositary shares,...
Published:
Bristol-Myers Squibb Company (NYSE: BMY) came out with earnings at $0.35 EPS and reaffirmed 2008 guidance of $1.36 to $1.46 GAAP EPS and $1.60 to $1.70 non-GAAP EPS. It also maintained a 2007 to...
Published:
Last Updated:
Medarex, Inc. (NASDAQ: MEDX) wants to clarify a few issues regarding the study halt from Pfizer (NYSE: PFE) this week on advanced melanoma. The company says that there are key differences between...
Published:
Bristol-Myers (NYSE: BMY) does not see much future in baby food. It is trying to sell its operation to a company where its is a better fit. According to the FT, that includes Pepsi (NYSE: PEP) and...
Published:
Those rummaging through the garbage of 52-week low lists are usually bottom-fishing investors or desperate CEOs. But, the list is so broad that it has become a tableau of the market as a whole,...
Published:
Some large companies, like Bristol-Myers (BMY), has already said that auction-rate securities on their balance sheets may have to be written down now that the market for this paper is illiquid. The...
Published:
CyDex Pharmaceuticals, Inc. has filed to come public via an IPO in what it lists for filing purposes as up to $50 million in securities sales. It has applied to have the common stock approved for...
Published:
On tonight’s MAD MONEY on CNBC, Jim Cramer wanted to look for stocks with both appreciation potential that also offer capital preservation. He, just like us, believes we are starting to price in...
Published:
Last Updated:
Early this week we are running a list of stocks that have been in a turnaround plan, yet the stocks and the businesses haven’t turned around. Could these be the stocks to watch for 2008? Pfizer...
Published:
Last Updated:
Medarex inc. (NASDAQ: MEDX) is seeing shares slapped in after-hours trading after the company is issuing disappointing news over the hopes for its Ipilimumab Pivotal Trials in patients with Advanced...
Published:
Last Updated:
According to Reuters, Nikon is seeing a sharp increase in demand from LCD makers. Reuters writes that the housing slump will last through 2009 and some home prices will drop 30%. Reuters reports the...
Published:
Bristol-Myers (BMY) showed the world its equivalent of the old Soviet "Five Year Plan" today. All of the talk up front was about becoming "a next-generation BioPharma company that pairs the scale and...
Published:
Plavix from Bristol-Myers (BMY) is the medical drug-thinner of choice. According to CNN Money, sales of the drug "totaled $3.4 billion in sales during the first nine months" Now Eli Lilly (LLY) has...
Published:
Medarex (NASDAQ:MEDX) is seeing shares being hit by a research note where Banc of America initiated coverage with a "SELL" rating. This is a fairly thin volume stock in pre-market trading, but...
Published:
Last Updated: